Becondogrel

吡康格雷

Report date: 2026/02/12 20:00:14
NME

Base Information

Drug NameBecondogrel
Drug Alias Name2-Oxoclopidogrelsbk002SBK-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsThrombosisPeripheral Arterial DiseaseAtherosclerosis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesChengdu Shibeikang Biomedical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Shibeikang Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsThrombosisPeripheral Arterial DiseaseAtherosclerosis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A